<DOC>
	<DOCNO>NCT00214201</DOCNO>
	<brief_summary>The purpose study determine whether Campath-1H induction therapy associate lymphocyte depletion permit long-term , rejection free renal allograft function absence maintenance calcineurin inhibitor ( CI ) therapy .</brief_summary>
	<brief_title>Campath-1H Induction Allow Discontinuation Calcineurin Inhibitors After Renal Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Alemtuzumab</mesh_term>
	<mesh_term>Calcineurin Inhibitors</mesh_term>
	<criteria>receive renal transplant , induction Campath1H , least 2 month calcineurin inhibitor therapy , CellCept , prednisone . Recipients HLAidentical livingdonor renal transplant ; PRA value &gt; 20 % within 30 day transplant ; GFR &lt; 40ml/min ; multiorgan transplant ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>